Center for Oncological Research (CORE),
Integrated Personalized & Precision Oncology Network (IPPON),
Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON)
Evelien Smits has not added Biography.
If you are Evelien Smits and would like to personalize this page please email our Author Liaison for assistance.
Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.
International journal of cancer Jan, 2004 | Pubmed ID: 14639612
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.
The oncologist Aug, 2008 | Pubmed ID: 18701762
Immunotherapy of acute myeloid leukemia: current approaches.
The oncologist Mar, 2009 | Pubmed ID: 19289488
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
Cancer immunology, immunotherapy : CII Jan, 2010 | Pubmed ID: 19449004
Dendritic cell-based cancer gene therapy.
Human gene therapy Oct, 2009 | Pubmed ID: 19656053
Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Journal of translational medicine , 2009 | Pubmed ID: 20021667
The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT.
Journal of immunological methods May, 2010 | Pubmed ID: 20214906
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2010 | Pubmed ID: 20631300
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers.
Human vaccines May, 2011 | Pubmed ID: 21422813
Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents.
Viral immunology Apr, 2011 | Pubmed ID: 21449725
Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.
Cancer immunology, immunotherapy : CII Jun, 2011 | Pubmed ID: 21519825
Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.
PloS one , 2011 | Pubmed ID: 21698118
Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?
Immunotherapy Oct, 2011 | Pubmed ID: 21995572
Dendritic cell vaccination in acute myeloid leukemia.
Cytotherapy Jul, 2012 | Pubmed ID: 22686130
Sampling site matters when counting lymphocyte subpopulations.
PloS one , 2012 | Pubmed ID: 22848485
NK cells: key to success of DC-based cancer vaccines?
The oncologist , 2012 | Pubmed ID: 22907975
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
PloS one , 2012 | Pubmed ID: 23284789
CD56 marks human dendritic cell subsets with cytotoxic potential.
Oncoimmunology Feb, 2013 | Pubmed ID: 23524451
Interferon α may be back on track to treat acute myeloid leukemia.
Oncoimmunology Apr, 2013 | Pubmed ID: 23734314
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.
Human vaccines & immunotherapeutics Sep, 2013 | Pubmed ID: 23778748
Tumoricidal activity of human dendritic cells.
Trends in immunology Nov, 2013 | Pubmed ID: 24262387
Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.
Clinical and vaccine immunology : CVI Mar, 2014 | Pubmed ID: 24429070
Loading of acute myeloid leukemia cells with poly(I:C) by electroporation.
Methods in molecular biology (Clifton, N.J.) , 2014 | Pubmed ID: 24619684
Clinical use of dendritic cells for cancer therapy.
The Lancet. Oncology Jun, 2014 | Pubmed ID: 24872109
HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.
Journal of cellular and molecular medicine Jul, 2014 | Pubmed ID: 24979331
Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.
Transplantation Jan, 2015 | Pubmed ID: 25050468
Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.
Pharmacology & therapeutics Feb, 2015 | Pubmed ID: 25281915
Interleukin-15: new kid on the block for antitumor combination therapy.
Cytokine & growth factor reviews Feb, 2015 | Pubmed ID: 25306466
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Cancer immunology, immunotherapy : CII Jul, 2015 | Pubmed ID: 25863943
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.
PloS one , 2015 | Pubmed ID: 25951230
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.
Pharmacological reviews Oct, 2015 | Pubmed ID: 26240218
Targeting immune checkpoints: New opportunity for mesothelioma treatment?
Cancer treatment reviews Dec, 2015 | Pubmed ID: 26433514
Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.
Oncoimmunology Nov, 2015 | Pubmed ID: 26451309
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.
PloS one , 2015 | Pubmed ID: 26492414
Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect.
Journal of immunology research , 2015 | Pubmed ID: 26605342
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.
Pharmacology & therapeutics Feb, 2016 | Pubmed ID: 26617219
Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Oncotarget Dec, 2015 | Pubmed ID: 26675759
Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.
Methods in molecular biology (Clifton, N.J.) , 2016 | Pubmed ID: 27033213
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.
Cancer research Aug, 2016 | Pubmed ID: 27325645
Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity.
Mediators of inflammation , 2016 | Pubmed ID: 27340343
The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells.
Oncotarget Nov, 2016 | Pubmed ID: 27659531
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells.
Journal of hematology & oncology Sep, 2016 | Pubmed ID: 27686372
IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.
Pharmacology & therapeutics Feb, 2017 | Pubmed ID: 27777088
Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.
Oncoimmunology , 2016 | Pubmed ID: 27853652
Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.
Oncotarget Feb, 2017 | Pubmed ID: 28099143
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma.
Oncoimmunology , 2017 | Pubmed ID: 28197385
CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.
Histopathology Sep, 2017 | Pubmed ID: 28383817
Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox.
Scientific reports Apr, 2017 | Pubmed ID: 28439065
Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion.
Cancer immunology research Aug, 2017 | Pubmed ID: 28637876
Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections.
The Journal of clinical investigation Sep, 2017 | Pubmed ID: 28783042
CD56 in the Immune System: More Than a Marker for Cytotoxicity?
Frontiers in immunology , 2017 | Pubmed ID: 28791027
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.
Blood Oct, 2017 | Pubmed ID: 28830889
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.
Oncotarget Aug, 2017 | Pubmed ID: 28915646
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.
Oncotarget Sep, 2017 | Pubmed ID: 29088768
Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients.
Oncotarget Oct, 2017 | Pubmed ID: 29163783
Anti-cancer capacity of plasma-treated PBS: effect of chemical composition on cancer cell cytotoxicity.
Scientific reports Nov, 2017 | Pubmed ID: 29184131
Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.
Immunogenetics Jun, 2018 | Pubmed ID: 29196796
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.
Oncoimmunology , 2018 | Pubmed ID: 29399410
Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.
Oncotarget Jan, 2018 | Pubmed ID: 29423088
Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.
Frontiers in immunology , 2018 | Pubmed ID: 29599770
Combining top-ranked immunotherapeutics in lung cancer.
The Lancet. Oncology May, 2018 | Pubmed ID: 29628313
Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review.
Pharmacology & therapeutics Sep, 2018 | Pubmed ID: 29660367
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.
Cancers Apr, 2018 | Pubmed ID: 29690507
Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.
Frontiers in immunology , 2018 | Pubmed ID: 29692776
The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
Cytokine & growth factor reviews Jun, 2018 | Pubmed ID: 29773448
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation.
Oncoimmunology , 2018 | Pubmed ID: 29900042
Memory CD4 T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus.
Genes and immunity Mar, 2019 | Pubmed ID: 29904098
Vaccine and immune cell therapy in non-small cell lung cancer.
Journal of thoracic disease May, 2018 | Pubmed ID: 29951309
Author Correction: Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox.
Scientific reports Jul, 2018 | Pubmed ID: 30002465
Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.
Vaccine Oct, 2018 | Pubmed ID: 30205979
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
Vaccines Sep, 2018 | Pubmed ID: 30235890
Reduction of Human Glioblastoma Spheroids Using Cold Atmospheric Plasma: The Combined Effect of Short- and Long-Lived Reactive Species.
Cancers Oct, 2018 | Pubmed ID: 30360539
Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing.
Frontiers in immunology , 2018 | Pubmed ID: 30464762
RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment.
Critical reviews in oncology/hematology Jan, 2019 | Pubmed ID: 30661662
Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) Mar, 2019 | Pubmed ID: 30937272
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.
International journal of molecular sciences May, 2019 | Pubmed ID: 31052546
CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15.
Cancers Jul, 2019 | Pubmed ID: 31336622
Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression.
International journal of molecular sciences Aug, 2019 | Pubmed ID: 31455014
Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment.
Cancers Sep, 2019 | Pubmed ID: 31480642
Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression.
Cancer immunology, immunotherapy : CII Oct, 2019 | Pubmed ID: 31511925
Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer.
Cancers Sep, 2019 | Pubmed ID: 31546858
The potential and controversy of targeting STAT family members in cancer.
Seminars in cancer biology Feb, 2020 | Pubmed ID: 31605750
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells.
Cancers Oct, 2019 | Pubmed ID: 31635070
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method.
Cancers Oct, 2019 | Pubmed ID: 31652572
Modifying the Tumour Microenvironment: Challenges and Future Perspectives for Anticancer Plasma Treatments.
Cancers Dec, 2019 | Pubmed ID: 31810265
New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia.
Cancer immunology, immunotherapy : CII May, 2020 | Pubmed ID: 31970440
Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?
Cancers Jan, 2020 | Pubmed ID: 32012714
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients.
Cancers Apr, 2020 | Pubmed ID: 32252405
Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status.
British journal of cancer Sep, 2020 | Pubmed ID: 32541873
SARS-CoV-2 and cancer: Are they really partners in crime?
Cancer treatment reviews Sep, 2020 | Pubmed ID: 32731090
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.
Clinical & translational immunology , 2020 | Pubmed ID: 32821382
Cold Atmospheric Plasma Treatment for Pancreatic Cancer-The Importance of Pancreatic Stellate Cells.
Cancers Sep, 2020 | Pubmed ID: 32998311
Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects.
Antioxidants (Basel, Switzerland) Nov, 2020 | Pubmed ID: 33260826
Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies.
Critical reviews in oncology/hematology Jan, 2021 | Pubmed ID: 33310278
Critical Evaluation of the Interaction of Reactive Oxygen and Nitrogen Species with Blood to Inform the Clinical Translation of Nonthermal Plasma Therapy.
Oxidative medicine and cellular longevity , 2020 | Pubmed ID: 33343810
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3.
Cancers Jan, 2021 | Pubmed ID: 33466653
Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?
Cancers Jan, 2021 | Pubmed ID: 33478080
Oxidation of Innate Immune Checkpoint CD47 on Cancer Cells with Non-Thermal Plasma.
Cancers Feb, 2021 | Pubmed ID: 33540720
Physical plasma-derived oxidants sensitize pancreatic cancer cells to ferroptotic cell death.
Free radical biology & medicine Apr, 2021 | Pubmed ID: 33636332
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update.
International journal of molecular sciences Feb, 2021 | Pubmed ID: 33670397
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer.
Cancers Feb, 2021 | Pubmed ID: 33673405
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests.
European journal of cancer (Oxford, England : 1990) May, 2021 | Pubmed ID: 33773276
Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects.
Diagnostics (Basel, Switzerland) Mar, 2021 | Pubmed ID: 33803146
Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer.
Redox biology Jun, 2021 | Pubmed ID: 33812801
Oxidative damage to hyaluronan-CD44 interactions as an underlying mechanism of action of oxidative stress-inducing cancer therapy.
Redox biology Jul, 2021 | Pubmed ID: 33895486
Cold Atmospheric Plasma Increases Temozolomide Sensitivity of Three-Dimensional Glioblastoma Spheroids via Oxidative Stress-Mediated DNA Damage.
Cancers Apr, 2021 | Pubmed ID: 33917880
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation.
Science advances May, 2021 | Pubmed ID: 33962944
A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy.
Journal of experimental & clinical cancer research : CR Jun, 2021 | Pubmed ID: 34172082
Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.
Cells Oct, 2021 | Pubmed ID: 34831159
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma.
Pharmacology & therapeutics Aug, 2022 | Pubmed ID: 34999181
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination.
eLife Jan, 2022 | Pubmed ID: 35074048
Cold Atmospheric Plasma Does Not Affect Stellate Cells Phenotype in Pancreatic Cancer Tissue in Ovo.
International journal of molecular sciences Feb, 2022 | Pubmed ID: 35216069
Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by Silencing of Programmed-Death Ligands.
Frontiers in immunology , 2022 | Pubmed ID: 35250967
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma.
Biomedicines Mar, 2022 | Pubmed ID: 35327475
Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?
Biomedicines Mar, 2022 | Pubmed ID: 35453573
Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer Immunotherapy.
Biomedicines May, 2022 | Pubmed ID: 35625811
Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects.
Pathology oncology research : POR , 2022 | Pubmed ID: 35645621
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.
Oncoimmunology , 2022 | Pubmed ID: 35800158
New Implications of Patients' Sex in Today's Lung Cancer Management.
Cancers Jul, 2022 | Pubmed ID: 35884463
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy.
Cancers Aug, 2022 | Pubmed ID: 36077610
The effect of local non-thermal plasma therapy on the cancer-immunity cycle in a melanoma mouse model.
Bioengineering & translational medicine Sep, 2022 | Pubmed ID: 36176603
The pro- and anti-tumoral properties of gap junctions in cancer and their role in therapeutic strategies.
Redox biology Oct, 2022 | Pubmed ID: 36228438
The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
Frontiers in immunology , 2022 | Pubmed ID: 36268020
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2022 | Pubmed ID: 36341493
Challenges in neoantigen-directed therapeutics.
Cancer cell Nov, 2022 | Pubmed ID: 36368320
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Cellular oncology (Dordrecht) Dec, 2022 | Pubmed ID: 36508089
Maxim Le Compte1,
Edgar Cardenas De La Hoz2,
Sofía Peeters1,
Evelien Smits1,
Filip Lardon1,
Geert Roeyen1,3,
Steve Vanlanduit2,
Hans Prenen1,4,
Marc Peeters1,4,
Abraham Lin1,5,
Christophe Deben1
1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp,
2Industrial Vision Lab, University of Antwerp,
3Department of Hepatobiliary Transplantation and Endocrine Surgery, University Hospital Antwerp (UZA),
4Department of Oncology, University Hospital Antwerp (UZA),
5Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved